Regeneron Intellectual Property definition
Examples of Regeneron Intellectual Property in a sentence
With respect to the licenses granted under this Article IV, and for the avoidance of doubt, Regeneron expressly reserves for itself and its Affiliates and Third Party licensees under the Regeneron Intellectual Property and Regeneron's interest in the Joint Inventions, the right to Manufacture and to Commercialize Licensed Products for use in the Field in the Territory in accordance with this Agreement.
Each Party hereby grants to the other Party and its Affiliates a non-exclusive, non-transferable, worldwide, royalty-free, research license, without the right to sublicense, under the Regeneron Intellectual Property and the Sanofi Intellectual Property, respectively, solely to perform the Discovery Program.
Her participation and input at A&M meetings was much appreciated.
For the further avoidance of doubt, Regeneron retains all rights in Regeneron Intellectual Property, Regeneron's interest in the Joint Inventions and Licensed Products not expressly licensed hereunder, including, without limitation the right to exploit Regeneron Intellectual Property and Regeneron's interest in Joint Inventions for purposes unrelated to the Licensed Products in the Field.
Subject to the terms and conditions of this Agreement and any license within the Regeneron Patent Rights, Regeneron hereby grants to Novartis and its Affiliates the right and license under the Regeneron Intellectual Property to manufacture, and to Co-Develop, Co-Commercialize and Co-Market the Trap-1 Product throughout the Trap-1 Territory for the Term of this Agreement.
The student fee is refunded if a complete drop is done during the 100% refund period.In extreme circumstances, tuition and lab/material fees may be refunded after the refund period.
The rights granted to Novartis and its Affiliates under the Regeneron Intellectual Property to sell or offer to sell the Trap-2 Product shall be sublicensable to Distributors of Novartis (but not with respect to distribution, marketing, sale or offer for sale of the Trap-2 Product in any country listed on SCHEDULE 10), and otherwise only with the prior written consent of Regeneron, which consent shall not be unreasonably withheld or delayed.
Typically the Concession Agreement will provide that, in the event of a dispute, the Developer and Department will first attempt to resolve it through good faith negotiations between their designated representatives.
In the event of a breach by a Sublicensee of any sublicense agreement which has or is reasonably likely to have a materially adverse effect on Regeneron or any of its Affiliates or any Regeneron Intellectual Property, then Regeneron may cause Company or its Affiliate to exercise, and the Company or its Affiliate will promptly exercise, any termination rights it may have under the sublicense with the Sublicensee.
The rights granted to Novartis and its Affiliates under the Regeneron Intellectual Property to sell or offer to sell the Trap-1 Product shall be sublicensable to Distributors of Novartis (but not with respect to distribution, marketing, sale or offer for sale of the Trap-1 Product in any country listed on SCHEDULE 10), and otherwise only with the prior written consent of Regeneron, which -27- <PAGE> consent shall not be unreasonably withheld or delayed.